Congress Materials

Medical Information
Saudi Arabia
 

This medical Information website is intended only for Healthcare Professionals in the Kingdom of Saudi Arabia. This information is not intended as medical advice. Responsibility for patient care resides with the healthcare professional on the basis of his or her professional license, experience and knowledge of the patient.

Please choose the category that best describes you.

This content is intended for Healthcare professionals in Saudi Arabia. Would you like to proceed?

I am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
SelectI am a healthcare professional registered to practice in KSAYes, I am a healthcare professional registered to practice in KSA
I am not a healthcare professionalNo, go back to the patient portal
SelectI am not a healthcare professionalNo, go back to the patient portal
Non-Saudi Arabia residents click here.
The information on this page pertains to select congresses, congress materials, therapeutic and disease areas. It is not intended to serve as a comprehensive overview of all congresses, congress materials, therapeutic and disease areas.
Poster
Schadendorf D, Dummer R, Robert C, Ribas A, Sullivan RJ, Panella T, McKean M, Santos ES, Brill K, Polli A, di Pietro A, Ascierto PA September 16, 2021 ESMO 2021 Skin Cancer

STARBOARD: Randomized Phase 3 Study of Encorafenib + Binimetinib + Pembrolizumab for First-Line Treatment of Metastatic or Unresectable Locally Advanced BRAF V600-Mutant Melanoma

View Presentation View Abstract Plain Language Summary
Oral Presentation
Dummer R, Flaherty KT, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsova I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, Edwards M, Ascierto PA September 20, 2021 ESMO 2021 Skin Cancer

5-Year Update on COLUMBUS: A Randomized Phase 3 Trial of Encorafenib + Binimetinib Versus Encorafenib or Vemurafenib in Patients With BRAF V600-Mutant Melanoma

View Presentation View Abstract Plain Language Summary
Poster
Williams JH, Reddy M, Zhang Y, Del Frari L, Matschke K, Litwiler K March 18, 2022 ASCPT 2022 Skin Cancer

Effect of Encorafenib in Combination With Binimetinib on Substrates for OATP1B1/3, BCRP, and CYP2B6 in Patients With BRAF V600-Mutant Unresectable or Metastatic Melanoma or Other Advanced Solid Tumors

View Presentation
Poster
Dummer R, Pathan N, Zhu Z, Robert C, Arance A, de Groot JWB, Garbe C, Gogas HJ, Gutzmer R, Krajsova I, Liszkay G, Loquai C, Mandala M, Schadendorf D, Yamazaki N, Edwards M, Cantey-Kiser J, di Pietro A, Deng S, Ascierto PA, Flaherty K April 12, 2022 AACR 2022 Skin Cancer

Molecular Correlates of Clinical Benefit From Circulating Tumor DNA (ctDNA): Analysis of the COLUMBUS Study

View Presentation